Evidence map›Paper›PMID 37893190›Full record

ReviewBiomedicines2023

Clinical Use and Treatment Mechanism of Molecular Hydrogen in the Treatment of Various Kidney Diseases including Diabetic Kidney Disease.

Shin-Ichi Hirano, Yusuke Ichikawa, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. [Mesothelial impairment induced by peritoneal dialysis and its potential protective strategies].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shin-Ichi HiranoDepartment of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura 247-0056, Japan.ORCID 0000-0002-8610-8922
Yusuke IchikawaDepartment of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura 247-0056, Japan.
Bunpei SatoDepartment of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura 247-0056, Japan.
Yoshiyasu TakefujiKeio University, 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan.ORCID 0000-0002-1826-742X
Fumitake SatohDepartment of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura 247-0056, Japan.
Musashino University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As diabetes rates surge globally, there is a corresponding rise in the number of patients suffering from diabetic kidney disease (DKD), a common complication of diabetes. DKD is a significant contributor to chronic kidney disease, often leading to end-stage renal failure. However, the effectiveness of current medical treatments for DKD leaves much to be desired. Molecular hydrogen (H

Indexed as

diabetic kidney diseaseinflammationmedical applicationmitochondrial dysfunctionmolecular hydrogenoxidative stressreactive oxygen species

Identifiers

PMID37893190
PMCPMC10603947
OpenAlexW4387701892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.